Correction to: Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
Crossref DOI link: https://doi.org/10.1007/s40262-022-01134-1
Published Online: 2022-05-17
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Badri, Prajakta http://orcid.org/0000-0003-1248-616X
Jiang, Xuemin
Borodovsky, Anna
Najafan, Nader
Kim, Jae
Clausen, Valerie A.
Goel, Varun
Habtemariam, Bahru
Robbie, Gabriel J.
Text and Data Mining valid from 2022-05-17
Version of Record valid from 2022-05-17
Article History
First Online: 17 May 2022